Thyrotoxicosis in pregnancy is rare. It is important to consider during pregnancy because uncontrolled thyrotoxicosis has increased risk to mother and foetus. Most common cause of Maternal thyrotoxicosis during pregnancy is Graves' disease. Other causes include gestational thyrotoxicosis, Multinodular goitre, Toxic adenoma and others.Early diagnosis and treatment should be given in order to prevent complications and ensure safe delivery and healthy baby.
Introduction
Thyrotoxicosis during pregnancy can pose serious maternal as well as foetal health hazards. Prevalence of thyrotoxicosis in pregnancy is about 0.2%. Graves' disease being the most common cause. Uncontrolled thyrotoxicosis causes both maternal and foetal complications including miscarriage, higher incidence of toxemia, heart failure, placental abruption, preterm delivery, premature labor and fetal complications like small, for gestational age, intrauterine growth retardation and low birth weight. Proper treatment of the disease can prevent potential adverse effects on mother and baby.
Materials and Methods
It is a limited retrospective study. We collected the case papers of patients treated by endocrinology unit of medicine department in Goa medical college, who have been diagnosed as thyrotoxicosis in pregnancy. Study period was 2009-2017. A total of 73 patients with the diagnosis of Pregnancy with thyrotoxicosis were registered in our records. We managed to get the correct contact numbers of around 60 of them. Only 43 responded to our telephonic calls and were willing to participate in in our study. We went through the case papers to find out the details of clinical symptoms, course of the disease, treatment received, complications during the pregnancy (both maternal and fetal).
Observations and Results
Median age of study population 29 years. 67% were primigravida. 33% were multigravida.33% had history of previous thyroid disease. Goiter and palpitations were the most common presenting symptoms followed by hyperemesis, tremors. In our study 67% were primi gravida, 33% were multigravida whereas it was 44% and 56% respectively in Murty N et al 5. MeanTSH in our study is 0.02µIU/ml in first trimister as compared to 0.036µIU/ml in study done by saraladevi et al. 4 and <0.02µIU/ml in study done by Murty N et al 5 .
11% had preterm delivery as compared to 5.5% in study done by saraladevi et al. 4
Conclusions
Overall thyrotoxicosis has significant effects on both mother and foetus. Early diagnosis and treatment should be given in order to prevent complications and ensure safe delivery and healthy baby.
Limitations
We included only patients with thyrotoxicosis in our study, hence overall prevalence could not be calculated. Small study population was another drawback of our study. Also, few patients lost for follow up. 
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